*Correspondence: Ze Wang, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
A network meta-analysis of 76 randomized controlled trials covering 39,246 patients found that tirzepatide produced the largest HbA1c reduction at negative 2.10% versus placebo, followed by semaglutide
Consulting with your doctor is important when experiencing persistent side effects to adjust the treatment as needed
Aim: This systematic review and meta-analysis aim to assess the efficacy and safety of GLP-1 receptor agonists in providing pain and symptom relief for individuals with IBS
Important considerations include: production experience quality management systems inventory planning International logistics support Stable supply capability reduces potential interruptions during research and product development stages
Those in the glutamine group also saw highly significant improvements in daily bowel movement frequency, Bristol Stool Scale scores, and intestinal permeability
